← back to search

Toshitaka Yajima

AstraZeneca (Japan) · JP
🔎 Find collaborators in Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Diabetes Treatment and Management, Potassium and Related Disorders, Viral Infections and Immunology Research, and Heart Failure Treatment and Management.
h-index
27
citations
2,712
works
102
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
BMC Nephrology 2023cited by 48position: middledoi
Association of Hyperkalemia and Hypokalemia with Patient Characteristics and Clinical Outcomes in Japanese Hemodialysis (HD) Patients
Journal of Clinical Medicine 2023cited by 5position: middledoi
Additional file 1 of Clinical impact of suboptimal RAASi therapy following an episode of hyperkalemia
Open MIND 2023cited by 0position: middledoi
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
Diabetes Obesity and Metabolism 2022cited by 42position: middledoi
Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study
Diabetes Obesity and Metabolism 2020cited by 224position: middledoi
Lower cardiorenal risk with <scp>sodium‐glucose</scp> cotransporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes without cardiovascular and renal diseases: A large multinational observational study
Diabetes Obesity and Metabolism 2020cited by 60position: middledoi
Cardiac-Specific Deletion of SOCS-3 Prevents Development of Left Ventricular Remodeling After Acute Myocardial Infarction
Journal of the American College of Cardiology 2012cited by 70position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Marcus Thuresson · Oncopeptides (Sweden)3 papers (2020–2022)Kåre I. Birkeland · Oslo University Hospital3 papers (2020–2022)Johan Bodegård · Statistics Norway3 papers (2020–2022)Anna Norhammar · Karolinska Institutet3 papers (2020–2022)— · 3 papers (2020–2022)Takashi Kadowaki · Oasis Hospital3 papers (2020–2022)Jan W. Eriksson · Uppsala University3 papers (2020–2022)Amitava Banerjee · University College Hospital3 papers (2020–2022)— · 2 papers (2023–2023)Ruiqi Zhang · Fudan University2 papers (2020–2020)Abiy Agiro · UCLA Medical Center2 papers (2023–2023)Eiichiro Kanda · National Cancer Center Hospital East2 papers (2023–2023)Matthew Arnold · University of Cambridge2 papers (2023–2023)Toyoaki Murohara · Ministry of Health Labour and Welfare2 papers (2023–2023)Krister Järbrink · Nanyang Technological University2 papers (2023–2023)Gerard C.M. Linssen · Ziekenhuis Groep Twente2 papers (2020–2022)Charles V. Pollack · University of Mississippi2 papers (2023–2023)— · 2 papers (2023–2023)Issei Komuro · National Institute of Animal Health2 papers (2020–2020)Anjay Rastogi · University of California, Los Angeles2 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Endocrinology, Diabetes and Metabolism · Cardiology and Cardiovascular Medicine →